| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2012-03-02 | RoActemra® (tocilizumab) | rheumatoid arthritis | 4 | Roche (Switzerland) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2012-03-02 | Grazax® (immunotherapy tablet) | grass pollen induced allergic rhinitis | ALK (Denmark) | Allergic diseases - Immune diseases | |
| 2012-02-29 | helminth parasite Necator americanus — or hookworm | multiple sclerosis | The University of Nottingham (UK) | Autoimmune diseases – Neurodegenerative diseases | |
| 2012-02-29 | EryDex® (solution of dexamethasone sodium phosphate for encapsulation into human erythrocytes.) | ataxia telangiectasia | 2 | EryDel (Italy) | Rare diseases |
| 2012-02-29 | PRX167700 | rheumatoid arthritis psoriasis |
1 | Proximagen (UK) | Autoimmune diseases - Inflammatory diseases - Dermatological diseases - Rheumatic diseases |
| 2012-02-28 | cariprazine | schizophrenia | 3 | Forest Laboratories (USA) Gedeon Richter (Hungary) | CNS diseases - Mental diseases |
| 2012-02-28 | HinsBet® (fast-acting human insulin) | type 1 diabetes | 2a | Adocia (France) | Metabolic diseases |
| 2012-02-27 | liposomal topical formulation of the enzyme human recombinant superoxide dismutase (project APN201) | prevention of radiation dermatitis in breast cancer patients. |
Apeiron Biologics (Austria) | Cancer Oncology | |
| 2012-02-21 | NX-1207 | benign prostatic hyperplasia |
3 | Recordati (Italy) Nymox Pharmaceutical (USA) | Urology |
| 2012-02-20 | VEGF Trap-Eye (aflibercept ophthalmic solution) | macular edema due to central retinal vein occlusion (CRVO) | 3 | Bayer Healthcare (Germany)Regeneron Pharmaceuticals (USA) | Ophtalmological diseases |
| 2012-02-17 | Vidofludimus | inflammatory bowel disease |
preclinical | 4SC (Germany) | Inflammatory diseases |
| 2012-02-16 | multimeric-001 vaccine (M-001) | influenza |
2 | BiondVax Pharmaceuticals (Israel) | Infectious diseases |
| 2012-02-15 | Vacc-4x | HIV-Aids | 2b | Bionor Pharma (Norway) | Infectious diseases |
| 2012-02-14 | SM101 | Primary Immune Thrombocytopenia |
1b-2a | SuppreMol (Germany) | Autoimmune diseases |
| 2012-02-14 | Epi proLung® BL assay | lung carcinoma |
Epigenomics (Germany-USA) | Cancer Oncology | |
| 2012-02-14 | eprotirome | heterozygous familial hypercholesterolemia (HeFH) |
3 | Karo Bio (Sweden) | Cardiovascular diseases - Genetic diseases - Rare diseases |
| 2012-02-10 | Ruconest® (Rhucin® in non-European territories - conestat alfa) | antibody-mediated rejection (AMR) after kidney transplantation | 2 | Pharming (The Netherlands) - Santarus (USA) | Transplantation |
| 2012-02-08 | eliglustat tartrate | Gaucher\'s disease |
2 | Genzyme (USA - MA), a Sanofi company (France) | Rare diseases - Genetic diseases |
| 2012-02-08 | GNbAC1 | multiple sclerosis | 1 | GeNeuro (Switzerland) | Autoimmune diseases - Neurodegenerative diseases |
| 2012-02-08 | GFT505 | NAFLD (non-alcoholic fatty liver disease) - NASH (non-alcoholic steatohepatitis) | long-term animal toxicology studies | Genfit (France) | Metabolic diseases - Liver diseases |
